Oral strip for generic Zofran
A new rapidly dissolving oral strip for ondansetron, the active ingredient in GSK's anti-emetic drug Zofran, has been developed in a Swiss-German collaboration.
A new rapidly dissolving oral strip for ondansetron, the active ingredient in GSK's anti-emetic drug Zofran, has been developed in a Swiss-German collaboration.
Canadian contract manufacturer Patheon has announced a $150m (€114m) investment by a private equity firm - a move the company sees as the best viable option to end its financial misery.
Novo Nordisk will continue to exploit the emerging importance of China in pharma research by establishing a new diabetes research foundation there.
The Portrait 630, launched by Labcyte at Pittcon 2007, allows accurate and reproducible matrix deposition for high quality MALDI imaging.
GlaxoSmithKline (GSK) has stopped development of several drugs, leaving some industry experts to wonder if the company's cap on research spending is stifling drug development.